Filing Details
- Accession Number:
- 0001181431-14-018869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-09 18:19:14
- Reporting Period:
- 2014-05-09
- Filing Date:
- 2014-05-09
- Accepted Time:
- 2014-05-09 17:19:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
893949 | Mednax Inc. | MD | Services-Hospitals (8060) | 650271219 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1218840 | B Karl Wagner | 1301 Concord Terrace Sunrise FL 33323 | Pres, American Anesthesiology | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-09 | 43,274 | $22.35 | 193,772 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-09 | 43,274 | $57.10 | 150,498 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-05-09 | 36,250 | $28.03 | 186,748 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-09 | 36,250 | $57.09 | 150,498 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2014-05-09 | 43,274 | $22.35 | 43,274 | $22.35 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2014-05-09 | 36,250 | $28.03 | 36,250 | $28.03 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-06-01 | 2016-06-01 | No | 4 | M | Direct |
20,000 | 2010-08-10 | 2017-08-10 | No | 4 | M | Direct |
Footnotes
- Sales made pursuant to Reporting Person's 10b5-1 trading plan.
- Sales of shares were executed in forty-two (42) separate transactions with prices ranging from $56.75 to $57.28 for a weighted average sales price of $57.0952.
- Sales of shares were executed in forty (40) separate transactions with prices ranging from $56.74 to $57.28 for a weighted average sales price of $57.0947.